Medivie Therapeutic (Israel) Market Value
| MDVI Stock | ILA 35.50 2.00 5.97% |
| Symbol | Medivie |
Medivie Therapeutic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medivie Therapeutic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medivie Therapeutic.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Medivie Therapeutic on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Medivie Therapeutic or generate 0.0% return on investment in Medivie Therapeutic over 30 days. Medivie Therapeutic is related to or competes with Homebiogas, Oron Group, Hiron Trade, Amir Marketing, Aura Investments, Adgar Investments, and Scope Metals. Medivie Therapeutic Limited develops and markets dental devices More
Medivie Therapeutic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medivie Therapeutic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medivie Therapeutic upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 18.19 | |||
| Value At Risk | (8.47) | |||
| Potential Upside | 6.39 |
Medivie Therapeutic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medivie Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medivie Therapeutic's standard deviation. In reality, there are many statistical measures that can use Medivie Therapeutic historical prices to predict the future Medivie Therapeutic's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.50) | |||
| Treynor Ratio | 1.22 |
Medivie Therapeutic Backtested Returns
Medivie Therapeutic has Sharpe Ratio of -0.23, which conveys that the firm had a -0.23% return per unit of risk over the last 3 months. Medivie Therapeutic exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medivie Therapeutic's Mean Deviation of 3.72, standard deviation of 4.56, and Risk Adjusted Performance of (0.11) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.6, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Medivie Therapeutic are expected to decrease at a much lower rate. During the bear market, Medivie Therapeutic is likely to outperform the market. At this point, Medivie Therapeutic has a negative expected return of -1.11%. Please make sure to verify Medivie Therapeutic's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Medivie Therapeutic performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.66 |
Good predictability
Medivie Therapeutic has good predictability. Overlapping area represents the amount of predictability between Medivie Therapeutic time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medivie Therapeutic price movement. The serial correlation of 0.66 indicates that around 66.0% of current Medivie Therapeutic price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 7.24 |
Medivie Therapeutic lagged returns against current returns
Autocorrelation, which is Medivie Therapeutic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medivie Therapeutic's stock expected returns. We can calculate the autocorrelation of Medivie Therapeutic returns to help us make a trade decision. For example, suppose you find that Medivie Therapeutic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medivie Therapeutic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medivie Therapeutic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medivie Therapeutic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medivie Therapeutic stock over time.
Current vs Lagged Prices |
| Timeline |
Medivie Therapeutic Lagged Returns
When evaluating Medivie Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medivie Therapeutic stock have on its future price. Medivie Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medivie Therapeutic autocorrelation shows the relationship between Medivie Therapeutic stock current value and its past values and can show if there is a momentum factor associated with investing in Medivie Therapeutic.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medivie Stock
Medivie Therapeutic financial ratios help investors to determine whether Medivie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medivie with respect to the benefits of owning Medivie Therapeutic security.